JP2003265069A - Method for producing clone animal - Google Patents

Method for producing clone animal

Info

Publication number
JP2003265069A
JP2003265069A JP2002068644A JP2002068644A JP2003265069A JP 2003265069 A JP2003265069 A JP 2003265069A JP 2002068644 A JP2002068644 A JP 2002068644A JP 2002068644 A JP2002068644 A JP 2002068644A JP 2003265069 A JP2003265069 A JP 2003265069A
Authority
JP
Japan
Prior art keywords
cells
embryos
embryo
nuclear transfer
cloned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002068644A
Other languages
Japanese (ja)
Other versions
JP3955931B2 (en
Inventor
Shinji Hashimura
慎二 橋村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanagawa Prefecture
Original Assignee
Kanagawa Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanagawa Prefecture filed Critical Kanagawa Prefecture
Priority to JP2002068644A priority Critical patent/JP3955931B2/en
Publication of JP2003265069A publication Critical patent/JP2003265069A/en
Application granted granted Critical
Publication of JP3955931B2 publication Critical patent/JP3955931B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To produce a clone embryo comprising many cells to improve a conception rate and thereby enable the increase in the production of a clone animal such as livestock. <P>SOLUTION: This method for producing the clone animal is characterized by subjecting embryos prepared by a nuclear transplantation method to an aggregation culture, namely combinedly using a cell aggregation method originally aiming the production of chimeras with a nuclear transplantation technique, thereby enabling the growth and generation of the embryos. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、核移植技術と細胞
集合(アグリゲーション)法を併用したクローン動物の
生産方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a cloned animal by using a nuclear transfer technique and a cell assembly (aggregation) method in combination.

【0002】[0002]

【従来の技術】近年、胚操作技術は非常にめざましい発
展をとげている。中でも核移植技術は、経済的価値の高
い同一の遺伝形質を有する個体を多数生産できる、クロ
ーン生産技術として、国内外で広く研究が進められ、め
ざましい発展をとげている。
2. Description of the Related Art In recent years, embryo manipulation technology has made remarkable progress. Among them, nuclear transfer technology has been extensively researched at home and abroad as a clone production technology capable of producing a large number of individuals having the same genetic trait with high economic value, and has made remarkable progress.

【0003】すなわち、まず、家畜での最初の核移植
は、Willadsenによりドナー細胞にヒツジの受
精卵を用いて行われた(Nature,320,63−
65,1986)。ついで、英国ロスリンのグループ
は、ヒツジ胚由来の培養細胞からクローン羊を作出し、
(Nature,380,64−66,1996)、さ
らにヒツジの乳腺細胞を用いて、クローン羊を作出(N
ature,385,810−813,1997)する
ことにより、ドナー細胞の未分化性は必須でないことを
明らかにした。
That is, first, the first nuclear transfer in livestock was performed by Willadsen using fertilized sheep eggs as donor cells (Nature, 320, 63-.
65, 1986). Then, the group of Roslin in England produced cloned sheep from cultured cells derived from sheep embryos,
(Nature, 380, 64-66, 1996), and further using sheep mammary gland cells to produce cloned sheep (N.
Nature, 385, 810-813, 1997), demonstrating that donor cell undifferentiation is not essential.

【0004】そして、1998年には、ウシ、マウスで
のクローン作出が報告され、哺乳動物において核移植技
術を用いれば、生体の体細胞を用いて個体を発生させる
ことができるという種を越えた普遍的事実が確定され、
今日に至っている。
Then, in 1998, cloning in bovine and mouse was reported, and it was possible to develop an individual by using somatic cells of a living body by using nuclear transfer technology in mammals. Universal facts are established,
It has reached today.

【0005】[0005]

【発明が解決しようとする課題】しかし、従来の核移植
技術にあっては、未分化及び分化細胞からのクローン動
物を生産することは可能であるが、作成された核移植胚
からのクローン産子の作出効率が極めて低いという問題
がある。
However, in the conventional nuclear transfer technique, it is possible to produce a cloned animal from undifferentiated and differentiated cells, but it is possible to produce a cloned animal from the prepared nuclear transfer embryo. There is a problem that the production efficiency of children is extremely low.

【0006】これは、生体由来胚に比較して受胎率が低
く、流産の発生率が高いことが主な原因である。特に、
受胎率が低いのは、従来の核移植技術により作成された
胚の細胞数が、同齢の生体由来胚に比較して少ないため
である。このように胚の細胞数が少ないのは、レシピエ
ント卵子の除核時に、核のみならずその周囲の細胞質を
同時に除去し、また胚の再構築後も比較的長時間にわた
り体外培養を行うためと考えられる。
[0006] This is mainly because the conception rate is low and the miscarriage rate is high as compared with the embryo derived from the living body. In particular,
The conception rate is low because the number of cells in the embryos created by the conventional nuclear transfer technique is smaller than that in embryos derived from living organisms of the same age. This low embryo cell number is due to simultaneous removal of not only the nucleus but also the cytoplasm around it during enucleation of the recipient egg, and in vitro culture for a relatively long time after reconstructing the embryo. it is conceivable that.

【0007】本発明は、このような従来の問題を解決す
るためになされたもので、一胚あたりの胚細胞数を増加
させて、受胎率ひいてはクローン動物の生産数増加につ
ながる実用的なクローン動物の生産方法を提供すること
を目的とする。
The present invention has been made in order to solve such a conventional problem, and it is a practical clone which increases the number of embryonic cells per embryo, resulting in an increased conception rate and thus an increased production number of cloned animals. It is intended to provide a method for producing animals.

【0008】[0008]

【課題を解決するための手段】本発明が提供するクロー
ン動物の生産方法は、次の(1)及び(2)に記載の方
法である。
The method for producing cloned animals provided by the present invention is the method described in the following (1) and (2).

【0009】(1)未分化細胞をドナー細胞とし、同細
胞のレシピエント卵子への核移植により作成したクロー
ン胚を、複数個集合培養し、単一の胚として発育させる
ことを特徴とするクローン動物の生産方法。
(1) A clone characterized in that undifferentiated cells are used as donor cells and a plurality of cloned embryos prepared by nuclear transfer of the same cells to a recipient egg are aggregate-cultured to develop as a single embryo How to produce animals.

【0010】(2)分化細胞をドナー細胞とし、同細胞
のレシピエント卵子への核移植により作成したクローン
胚を、複数個集合培養し、単一の胚として発育させるこ
とを特徴とするクローン動物の生産方法。
(2) A cloned animal characterized by using a differentiated cell as a donor cell and carrying out collective culture of a plurality of cloned embryos prepared by nuclear transfer of the same cells to a recipient egg to develop as a single embryo Production method.

【0011】本発明が提供するクローン動物の生産方法
は、従来のキメラを作出する手法である細胞集合(アグ
リゲーション)法を応用することで、生体由来胚とほぼ
同数の細胞数を持つ胚(核移植集合胚)を作出すること
を可能としたものである。
The method for producing a cloned animal provided by the present invention is the application of the conventional cell assembly (aggregation) method for producing a chimera to obtain an embryo (nuclear It is possible to create transplanted embryos).

【0012】この生産方法によれば、図1に示すよう
に、核移植技術により作成された胚を複数個集合し、1
つの胚として発育させることでクローン胚を再構築し、
体外で移植可能胚に発育させた後、仮親の子宮内に移植
しクローン動物を作出することができる。
According to this production method, as shown in FIG. 1, a plurality of embryos produced by the nuclear transfer technique are collected and
Reconstruct the cloned embryo by developing as one embryo,
After development into a transplantable embryo in vitro, the embryo can be transplanted into the uterus of a foster mother to create a cloned animal.

【0013】ここにいう細胞集合(アグリゲーション)
法は、細胞質同士を密着させるだけであり、比較的容易
に操作を行うことが可能であり、マニュピレーション装
置等は必要としない。
The cell aggregation (aggregation) referred to here
The method merely involves bringing the cytoplasms into close contact with each other, and the operation can be performed relatively easily, and a manipulation device or the like is not required.

【0014】この手法により作成された核移植集合胚に
よれば、実施例で明らかにしたように、高い受胎率を得
ることができる。また、生産された個体の遺伝形質は、
キメラではなく、クローンであることも実証できた。
According to the nuclear transfer ensemble produced by this method, a high conception rate can be obtained as clarified in Examples. In addition, the genetic traits of the produced individual are
It was also possible to demonstrate that it was not a chimera but a clone.

【0015】本発明が対象とする動物はヒト以外の哺乳
動物である。
The animals targeted by the present invention are mammals other than humans.

【0016】ドナー細胞は、初期胚由来もしくは初期胚
より樹立された胚性幹細胞など未分化細胞、胎仔由来も
しくは生体から得られる分化細胞のいずれでもよく、特
定の種類には限定されない。
The donor cells may be undifferentiated cells such as embryonic stem cells derived from early embryos or established from early embryos, or embryonic stem cells or differentiated cells obtained from living organisms, and are not limited to particular types.

【0017】ドナー細胞の培養は、それぞれの細胞に適
合した公知の手法で行うことができる。
Cultivation of donor cells can be carried out by a known method suitable for each cell.

【0018】レシピエント卵子も通常の核移植手法に使
用されるものでよい。しかし、生産されるクローン動物
のミトコンドリアDNAがキメラを示すことは避けたほ
うがよい。できるだけ同一個体の卵巣からのみ採取した
卵子を利用するのが望ましい。
Recipient eggs may also be those used in conventional nuclear transfer techniques. However, it is better to avoid that the produced mitochondrial DNA of the cloned animal shows chimera. It is desirable to use eggs collected from the ovaries of the same individual as much as possible.

【0019】また、レシピエント卵子には、除核操作後
確実に除核が確認されたもののみを用いる。ドナー細胞
のレシピエント卵子への核移植は、公知の手法で行う。
すなわち、細胞融合もしくは核の挿入により核の置換を
行った後、活性化処理を施し胚の再構築を行う。
As the recipient egg, only one that is confirmed to be enucleated after the enucleation operation is used. Nuclear transfer of a donor cell to a recipient egg is performed by a known method.
That is, after nuclear replacement is performed by cell fusion or nuclear insertion, activation treatment is performed to reconstruct the embryo.

【0020】作成されたクローン胚(核移植胚)は、桑
実胚までに透明帯を除去し、裸化した複数個の胚の細胞
同士を集合し密着させる。このとき、集合に用いる胚
は、適切な発育ステージにある、なるべく変性細胞の少
ない形態的に良質な胚のみを選び出して利用する。
The cloned embryo (nuclear transfer embryo) thus prepared has the zona pellucida removed up to the morula and the cells of a plurality of naked embryos are assembled and brought into close contact with each other. At this time, as embryos used for assembly, only embryos that are in an appropriate developmental stage and have few morphologically good cells and are morphologically good are selected and used.

【0021】集合した胚は、1つの胚として胚盤胞期胚
にまで発育することを確認し、仮親たる受胚動物に移植
を行い、クローン動物を誕生させる。
After confirming that the collected embryos develop into blastocyst stage embryos as one embryo, the embryos are transplanted to a recipient embryo recipient animal to give birth to a cloned animal.

【0022】[0022]

【発明の実施の形態】DETAILED DESCRIPTION OF THE INVENTION

【0023】[0023]

【実施例】以下に実施例のクローン動物の生産方法を工
程順に説明する。
EXAMPLES The method for producing cloned animals of the examples will be described below in the order of steps.

【0024】(1)と殺後の雌牛から卵巣を速やかに摘
出し、これを25〜30℃に保温したリンゲル液に入れ
て実験室へ持ち帰り、19G注射針を用いて直径8mm
以下の小卵胞から吸引法により未受精卵母細胞を採取し
た。
(1) Ovary was promptly removed from the cow after slaughter, put in Ringer's solution kept at 25 to 30 ° C. and brought back to the laboratory, and a diameter of 8 mm was used using a 19G needle.
Unfertilized oocytes were collected from the following small follicles by the aspiration method.

【0025】(2)採取した未受精卵母細胞の中から、
実体顕微鏡による形態観察で卵丘細胞が緊密に付着した
もののみを選抜し、これを20%非働化子牛血清(C
S;Gibco)添加D−PBS(CSPBS)で2回
洗浄した後、5%非働化子牛血清添加TCM199(C
S199)に移して3回洗浄し、その後、600μl当
たり約80個の割合で35mmシャーレ(FALCO
N)に移し、CO2インキュベーター内(3%CO2、9
7%空気、38.5℃)で、約20〜22時間の成熟培
養を行った。
(2) From among the unfertilized oocytes collected,
Only those to which the cumulus cells were tightly attached were selected by morphological observation using a stereoscopic microscope, and 20% inactivated calf serum (C
S; Gibco) -added D-PBS (CSPBS) twice, and then 5% inactivated calf serum-added TCM199 (C
S199) and wash 3 times, and then, about 80 pieces per 600 μl, 35 mm petri dish (FALCO).
N), and in a CO 2 incubator (3% CO 2 , 9%
Maturation culture was carried out in 7% air at 38.5 ° C for about 20 to 22 hours.

【0026】(3)成熟培養後の卵子をヒアルロニダー
ゼ(330IU/ml,Sigma)で処理し、その中
からパスツールピペットで卵丘細胞を除去し、第一極体
の放出が確認できた卵細胞質の均一な卵子を選抜し、こ
れをレシピエント卵子とした。
(3) Oocytes after maturation culture were treated with hyaluronidase (330 IU / ml, Sigma), cumulus cells were removed from them with a Pasteur pipette, and release of the first polar body was confirmed. No. 1 uniform egg was selected and used as a recipient egg.

【0027】(4)ドナー細胞には、卵管由来の細胞を
用いた。その細胞は、細胞数が3×106個/mlとな
るように、20%非働化胎仔血清(FBS;BioWh
ittaker)添加DMEMにて調整して35mmシ
ャーレ(Falcon)に移し、CO2インキュベータ
ー内(3%CO2、97%空気、39.5℃)で培養し
た。
(4) Oviduct-derived cells were used as donor cells. The cells contained 20% inactivated fetal bovine serum (FBS; BioWh) so that the cell number became 3 × 10 6 cells / ml.
It was adjusted with DMEM containing ittaker), transferred to a 35 mm Petri dish (Falcon), and cultured in a CO 2 incubator (3% CO 2 , 97% air, 39.5 ° C.).

【0028】(5)細胞がシャーレにてコンフルエント
の状態まで発育したら、トリプシン溶液(Trypsi
n−EDTA;Gibco)を用いてシャーレ表面から
単離し、再び細胞数が3×106個/mlとなるよう
に、20%FBS添加DMEMにて調整し、同様に培養
を行った。
(5) When the cells have grown to a confluent state in a petri dish, trypsin solution (Trypsi)
It was isolated from the Petri dish surface using n-EDTA; Gibco), adjusted again with 20% FBS-added DMEM so that the number of cells would be 3 × 10 6 cells / ml, and cultured in the same manner.

【0029】この操作を4回から6回繰り返した後、細
胞がコンフルエントの状態まで発育したら、0.5%F
BS添加DMEMにて5日間の血清飢餓培養を行い、こ
れを核移植に用いた。
After repeating this operation 4 to 6 times, when the cells grow to a confluent state, 0.5% F
Serum starvation culture was performed for 5 days in BS-added DMEM, and this was used for nuclear transfer.

【0030】(6)核移植操作は、まず、倒立顕微鏡下
でマイクロマニュピレーターに取り付けたホールディン
グピペットとカッティングニードルを操作し、成熟培養
を行ったレシピエント卵子の第一極体付近の透明帯を切
開した。
(6) For the nuclear transfer operation, first, a holding pipette and a cutting needle attached to a micromanipulator are operated under an inverted microscope to incise the zona pellucida near the first polar body of the recipient egg that has undergone maturation culture. did.

【0031】(7)次に、切開済みの卵子を、CSPB
Sを媒液にして作成したサイトカラシンB(5μg/m
l,sigma)に移し、極体とともにその近くの細胞
質を透明帯外に押し出して除核処理を行った。
(7) Next, the incised egg is replaced with CSPB.
Cytochalasin B (5 μg / m
1, sigma), and the cytoplasm in the vicinity of the polar body was pushed out of the zona pellucida for enucleation treatment.

【0032】(8)押し出された細胞質は、ヘキスト3
3342(Calbiochem)にて染色し、UV励
起により染色体の有無を確認した。このようにして除核
が確認された卵子のみをその後の操作に供した。
(8) The extruded cytoplasm is Hoechst 3
It was stained with 3342 (Calbiochem) and the presence or absence of the chromosome was confirmed by UV excitation. Only the ova confirmed to be enucleated in this manner were subjected to the subsequent operation.

【0033】(9)除核がなされたレシピエント卵子
は、CS199に移し、その囲卵腔内にホールディング
ピペットとインジェクションピペットを用いてドナー細
胞を挿入した。
(9) The enucleated recipient egg was transferred to CS199, and donor cells were inserted into the perivitelline cavity using a holding pipette and an injection pipette.

【0034】(10)成熟培養開始から約24時間目に
卵子とドナー細胞の融合操作を行った。融合液には修正
ZFM(Zimmerman cell fusion
medium)を用い、ニードル型電極でレシピエン
ト卵子とドナー細胞を挟み込み、融合機(ECM200
0;BTX)にて23〜24V−17μsec×2回/
150μmの条件で直流パルスを通電し、胚の再構築を
行った。
(10) About 24 hours after the initiation of maturation culture, fusion operation of an egg and a donor cell was performed. Modified ZFM (Zimmerman cell fusion)
medium), the recipient egg and the donor cell are sandwiched by needle type electrodes, and a fusion machine (ECM200
0; BTX) 23-24V-17 μsec × 2 times /
A DC pulse was applied under the condition of 150 μm to reconstruct the embryo.

【0035】(11)融合処理が終了した融合卵子は、
10μMCaイオノフォアA23187(Sigma)
を添加したPBSにて5分間、CS199を媒液にして
作成したシクロヘキシミド(10μg/ml,Sigm
a)にて6時間培養し、複合活性化処理を行った。
(11) The fused egg which has been fused is
10 μM Ca Ionophore A23187 (Sigma)
Cycloheximide (10 μg / ml, Sigma
It culture | cultivated for 6 hours in a), and performed the composite activation process.

【0036】(12)処理後、融合及び変性の有無を確
認し、融合成功胚の発生培養を行った。発生培養は、5
%非働化子牛血清添加CR1aa(CSCR1)によ
り、5%CO2、95%空気、38.5℃の条件下で行
った。発生培養開始後48時間目に分割検査を行い、分
割を行ったもののみの培養を継続した。
(12) After the treatment, the presence or absence of fusion and denaturation was confirmed, and the successful fusion embryo was cultured for development. Developmental culture is 5
CR1aa (CSCR1) supplemented with% inactivated calf serum was performed under the conditions of 5% CO2, 95% air and 38.5 ° C. Forty-eight hours after the initiation of developmental culture, a division test was performed, and the culture of only the divided cells was continued.

【0037】表1に核移植の成績を電気融合率及び分割
率で示す。
Table 1 shows the results of nuclear transfer in terms of electrofusion rate and division rate.

【0038】[0038]

【表1】 (13)融合後72〜96時間後に8細胞以上に分割し
た胚を選び、これをD−PBSを媒液にして作成したア
クチナーゼE(5mg/ml,科研製薬)に約30秒間
浸漬し、膨化した透明帯を除去することで割球を裸化し
た。
[Table 1] (13) 72 to 96 hours after the fusion, an embryo divided into 8 cells or more is selected, and this is swollen by immersing it in Actinase E (5 mg / ml, Kaken Pharmaceutical Co., Ltd.) prepared with D-PBS as a medium for about 30 seconds. The blastomer was made naked by removing the transparent zone.

【0039】(14)裸化した割球を、細く引いたパス
ツールピペットで3胚同時に軽くピペッティングするこ
とにより、割球同士を密着させた。
(14) The naked blastomere was lightly pipetted simultaneously with three embryos with a thin Pasteur pipette to bring the blastomere into close contact with each other.

【0040】(15)密着した胚は、オイルにてカバー
した20μlのCSCR1に移し、融合から7日間培養
を継続した。
(15) The closely attached embryo was transferred to 20 μl of CSCR1 covered with oil, and the culture was continued for 7 days after fusion.

【0041】(16)7日目に胞胚腔を確認した胚のみ
発生胚とし、20%FBS及び100μMβメルカプト
エタノール添加TCM199(βME199)に移し、
24時間の培養を続けた。
(16) On day 7, only embryos with confirmed blastocoel cavity were used as developing embryos and transferred to TCM199 (βME199) containing 20% FBS and 100 μM β-mercaptoethanol.
The culture was continued for 24 hours.

【0042】表2に集合の有無を基準とする胚の発生率
を示す。
Table 2 shows the incidence of embryos based on the presence or absence of sets.

【0043】[0043]

【表2】 表2は、分割した核移植胚を集合させれば、確実に移植
可能な胞胚腔を形成する胚を得ることができることを示
している。
[Table 2] Table 2 shows that if the divided nuclear transfer embryos are assembled, it is possible to obtain embryos that reliably form a blastocoel cavity that can be transplanted.

【0044】(17)培養後、2重染色により、内部細
胞塊及び栄養膜細胞の細胞数を測定した。
(17) After culturing, the number of inner cell mass and trophoblast cells was measured by double staining.

【0045】表3にその細胞数を示す。比較のために、
生体由来胚、体外受精胚、核移植胚についても示した。
Table 3 shows the number of cells. For comparison,
The biological embryo, in vitro fertilized embryo, and nuclear transfer embryo are also shown.

【0046】[0046]

【表3】 表3から明らかなように、集合により作成された胚は、
従来の核移植胚に比較し細胞数が増加し、生体由来胚と
比較し遜色がないことが判る。
[Table 3] As is clear from Table 3, the embryos created by the assembly
It can be seen that the number of cells is increased as compared with the conventional nuclear transfer embryo, and it is comparable to the embryo derived from the living body.

【0047】図2は、実施例の方法により作成された核
移植集合胚と従来の方法により作成された核移植胚を示
す。同図から明らかなように、実施例の方法により作成
された胚は、形態的に細胞数が多く内部細胞塊が明瞭で
あり、良質な胚であると判断できる。
FIG. 2 shows a nuclear transfer assembled embryo prepared by the method of the example and a nuclear transfer embryo prepared by the conventional method. As is clear from the figure, the embryos produced by the method of the example have a morphologically large number of cells and a clear inner cell mass, and can be judged to be good quality embryos.

【0048】(18)形態の良好な胚は、発情から8日
目に同調した受卵牛へ移植を行った。
(18) Embryos of good morphology were transplanted to the recieved cows on the 8th day after estrus.

【0049】表4にその移植成績を示す。表4から明ら
かなように受胎率の向上に伴い、生存個体生産率も向上
していることが分る。
Table 4 shows the transplantation results. As is clear from Table 4, the production rate of surviving individuals also improves as the conception rate increases.

【0050】[0050]

【表4】 [Table 4]

【0051】[0051]

【発明の効果】以上説明したように、本発明によれば、
本来キメラを作出することを目的とする細胞集合(アグ
リゲーション)法を核移植技術と併用することによっ
て、核移植により作成された胚を複数個集合培養するよ
うにしたので、一胚あたりの胚細胞数を増加させて、受
胎率の向上を図ることができ、したがって、クローン動
物の生産数の増加を図ることができる。
As described above, according to the present invention,
By combining the cell aggregation (aggregation) method, which was originally intended to create chimeras, with the nuclear transfer technology, multiple embryos created by nuclear transfer were collectively cultured, so that embryo cells per embryo By increasing the number, the conception rate can be improved, and thus the number of cloned animals produced can be increased.

【図面の簡単な説明】[Brief description of drawings]

【図1】 本発明に係るクローン動物の生産方法を示す
工程図
FIG. 1 is a process diagram showing a method for producing a cloned animal according to the present invention.

【図2】 実施例のクローン動物の生産方法によって作
成された核移植集合胚を示す顕微鏡写真
FIG. 2 is a micrograph showing a nuclear transfer ensemble embryo produced by the method for producing a cloned animal of Example.

【図3】 従来のクローン動物の生産方法によって作成
された核移植胚の顕微鏡写真
FIG. 3 is a micrograph of a nuclear transfer embryo produced by a conventional method for producing a cloned animal.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 未分化細胞をドナー細胞とし、同細胞の
レシピエント卵子への核移植により作成したクローン胚
を、複数個集合培養し、単一の胚として発育させること
を特徴とするクローン動物の生産方法。
1. A cloned animal, wherein undifferentiated cells are used as donor cells, and a plurality of cloned embryos prepared by nuclear transfer of the same cells to a recipient egg are aggregate-cultured to develop as single embryos. Production method.
【請求項2】 分化細胞をドナー細胞とし、同細胞のレ
シピエント卵子への核移植により作成したクローン胚
を、複数個集合培養し、単一の胚として発育させること
を特徴とするクローン動物の生産方法。
2. A cloned animal characterized in that a plurality of cloned embryos prepared by nuclear transfer of the differentiated cells as donor cells to recipient ova are developed as single embryos. Production method.
JP2002068644A 2002-03-13 2002-03-13 Clone cattle production method Expired - Fee Related JP3955931B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002068644A JP3955931B2 (en) 2002-03-13 2002-03-13 Clone cattle production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002068644A JP3955931B2 (en) 2002-03-13 2002-03-13 Clone cattle production method

Publications (2)

Publication Number Publication Date
JP2003265069A true JP2003265069A (en) 2003-09-24
JP3955931B2 JP3955931B2 (en) 2007-08-08

Family

ID=29199688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002068644A Expired - Fee Related JP3955931B2 (en) 2002-03-13 2002-03-13 Clone cattle production method

Country Status (1)

Country Link
JP (1) JP3955931B2 (en)

Also Published As

Publication number Publication date
JP3955931B2 (en) 2007-08-08

Similar Documents

Publication Publication Date Title
Lagutina et al. Comparative aspects of somatic cell nuclear transfer with conventional and zona-free method in cattle, horse, pig and sheep
WO1995017500A1 (en) Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
JPH04500909A (en) Induction of pluripotent embryonic cell lines from livestock
Kim et al. Improved preimplantation development of porcine somatic cell nuclear transfer embryos by caffeine treatment
Song et al. Modification of maturation condition improves oocyte maturation and in vitro development of somatic cell nuclear transfer pig embryos
CN1407851A (en) Improved method for production porcine clone embryos via somatic cell nuclear transfer
US20120142107A1 (en) Method and system for somatic cell nuclear transfer
JP3842597B2 (en) G1 phase cell collection method and nuclear transfer method using the cell
Meena et al. Development of water buffalo (Bubalus bubalis) embryos from in vitro matured oocytes reconstructed with fetal skin fibroblast cells as donor nuclei
Prather et al. Cloning of embryos
JP3955931B2 (en) Clone cattle production method
Ushijima Application study of developmental engineering for livestock production
Picard et al. The micromanipulation of farm animal embryos
JP4119513B2 (en) How to make cloned animals
Miyano et al. In vitro growth of oocytes from domestic species
JP2005523685A (en) Somatic embryonic stem cells and their differentiated progeny
Bori Developmental potency of goat embryos produced by intra cytoplasmic sperm injection and in vitro fertilization.
Lee et al. Production of cloned sei whale (Balaenoptera borealis) embryos by interspecies somatic cell nuclear transfer using enucleated pig oocytes
KR20100124891A (en) Establishment and characterization of embryonic stem-like cells from porcine somatic cell nuclear transfer blastocysts
KR20080077779A (en) A method to improve in vitro production of pig embryos
KR20070089100A (en) Dual pipet and method for enucleation, nuclear transplantation and somatic animal clon production by using the same
Kim GhangYong et al. Improved preimplantation development of porcine somatic cell nuclear transfer embryos by caffeine treatment.
Stice et al. Current successes in cloning mammalian embryos
CN116761894A (en) Embryo twinning method
KR20060117457A (en) Insulin-like growth factor-1 improve viability in porcine parthenotes and cloned embryos

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060228

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070109

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070222

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070410

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110518

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120518

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130518

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees